Peer-reviewedCC BY-NC-NDJAMA oncology
Neoadjuvant Stereotactic Ablative Radiotherapy Before Inferior Vena Cava Thrombectomy for Renal Cell Carcinoma : A Phase 2 Nonrandomized Clinical Trial
6 affiliations
- 1Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas
- 2Department of Urology, University of Texas Southwestern Medical Center, Dallas
- 3Department of Health Data Science and Biostatistics, University of Texas Southwestern Medical Center, Dallas
- 4Department of Pathology, University of Texas Southwestern Medical Center, Dallas
- 5Department of Abdominal Imaging, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston
- 6Department of Cardiovascular and Thoracic Surgery, University of Texas Southwestern Medical Center, Dallas
Related
- Postoperative radiotherapy versus systemic therapy alone for locally advanced esophageal squamous cell carcinoma following neoadjuvant chemoimmunotherapy
- Definitive radiotherapy versus surgery after neoadjuvant immunochemotherapy for locally advanced esophageal squamous cell carcinoma: a propensity score-matched study of efficacy and safety
- Intensity-modulated radiotherapy combined with albumin-bound paclitaxel and platinum-based chemotherapy for locoregional recurrent cervical cancer: a single-institutional phase II investigator-initiated nonrandomized clinical trial
- Spontaneous Pneumothorax During Stereotactic Body Radiotherapy for Pulmonary Metastasis From Osteosarcoma: A Case Report and Literature Review
- 473 Effect of nivolumab with or without relatlimab after stereotactic body radiotherapy in patients with advanced esophagogastric cancer
BibTeX
@article{hannan2026neoadjuvant,
title = {{Neoadjuvant Stereotactic Ablative Radiotherapy Before Inferior Vena Cava Thrombectomy for Renal Cell Carcinoma : A Phase 2 Nonrandomized Clinical Trial}},
author = {Raquibul Hannan and Lin Lin and Ryan Assadi and Laurentiu M. Pop and Lily Robles and Faya Zhang and Oscar Mulvaney and Ang Gao and Payal Kapur and Ivan Pedrosa and Aurelie Garant and Daniel Yang and Chul Ahn and Michael Wait and Robert Timmerman and Vitaly Margulis},
journal = {JAMA oncology},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13673378},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Neoadjuvant Stereotactic Ablative Radiotherapy Before Inferior Vena Cava Thrombectomy for Renal Cell Carcinoma : A Phase 2 Nonrandomized Clinical Trial
AU - Raquibul Hannan
AU - Lin Lin
AU - Ryan Assadi
AU - Laurentiu M. Pop
AU - Lily Robles
AU - Faya Zhang
AU - Oscar Mulvaney
AU - Ang Gao
AU - Payal Kapur
AU - Ivan Pedrosa
AU - Aurelie Garant
AU - Daniel Yang
AU - Chul Ahn
AU - Michael Wait
AU - Robert Timmerman
AU - Vitaly Margulis
PY - 2026
DA - 2026/10/15
JO - JAMA oncology
UR - https://europepmc.org/article/PMC/PMC13673378
SN - 2374-2437
SN - 2374-2445
ER -